Harvard Pilgrim Health Care Home
  Learn more.
  Sign up for HPHConnect.
Medical Management
For Your Patient
News Center
Network Matters
Newsletter Archives
Newsletter Registration
Office Support
Provider Manual
Medicare Advantage
Research & Teaching
Resources & Links
Print    Text Size

Network Matters
News and Information for the
Harvard Pilgrim Health Care Network

March 2018

Updates to Biofeedback Medical Policy

Harvard Pilgrim has updated our commercial Biofeedback Medical Policy. Under the updated policy, which is effective immediately, biofeedback therapy will be reimbursed for the following:

  • Muscle re-education of specific muscle groups
  • Treatment of pathological muscle abnormalities of spasticity, incapacitating muscle spasms, or muscle weakness, when conventional treatments have not been successful

The policy also includes additional criteria for ongoing biofeedback treatment, which Harvard Pilgrim will reimburse as medically necessary for up to 2-3 visits per week, for no longer than 6-8 weeks for single or combination medical conditions. Treatment plans with no benefit after 4 weeks of therapy may be re-evaluated. For complete criteria and coverage exclusions, please refer to Harvard Pilgrim’s updated Biofeedback Medical Policy.

Email this article to a colleague   

Network Matters Archives

Download printer-friendly version


New Preferred Biologics Drugs for Step Therapy

2017 Physician Group Honor Roll Announced  


Genetic Testing Authorization Updates

Update: Monitored Anesthesia Care for GI for Endoscopic Procedures

Reminder: UM Decision-Making and Communications

National Healthcare Decisions Day Emphasizes Advance Care Planning

Reminder: Refer Members to Participating Laboratories

Reminder: No Cost Share for Naloxone and Narcan Nasal Spray

Gender Reassignment Services Medical Review Criteria Updates

Updated: Invasive Treatment of Urinary Incontinence Criteria

Updates to Formulas and Enteral Nutrition Medical Review Criteria

Updates to Biofeedback Medical Policy

New Codes Covered for Varicose Veins with Prior Authorization


Reminders and Guidelines when Coding for Cancer

Enhancements to 271 Eligibility Response Transactions

Keep Panel Status and Demographic Information Up to Date

Reminder: Use the Correct Form for Provider Changes for Quicker Service


Eric H. Schultz,
President and Chief Executive Officer

Robert Farias,
Senior Vice President, Corporate Network Strategy

Annmarie Dadoly,

Joseph O'Riordan,

Kristin Edmonston,
Production Coordinator